The Latest Cardiac and Vascular News
CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its ECG Analysis Platform. The platform, developed in collaboration with Geisinger, aids clinicians in identifying patients at increased risk of developing atrial […]
WASHINGTON, March 23, 2021 /PRNewswire/ — Congenital heart disease (CHD) affects six out of 1,000 babies born in the U.S. each year and is often complicated by arrhythmias, a condition where the heart beats too rapidly, too slowly or irregularly due to a misfiring of the body’s electrical impulses. While the last decade […]
–Galaxy’s proprietary CENTAURI™ system on track for EU registration and US pivotal trial start later this year; shows best-in-class potential SAN CARLOS, Calif., March 16, 2021 /PRNewswire/ — ATP, a leader in life science venture capital, announced today $18M in Series A financing for its portfolio company Galaxy Medical, Inc. The funds are being […]
This money will allow for the expansion of remote recruitment of participants for this research that aims to treat the heart and help the brain MONTREAL, March 16, 2021 (GLOBE NEWSWIRE) — The Montreal Heart Institute (MHI) announces that the BRAIN-AF study has received a $1.4 million grant from the Canadian […]
AUSTIN, Texas, March 16, 2021 (GLOBE NEWSWIRE) — SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Dr. Waqaas Al-Siddiq, CEO of Biotricity Inc. (OTCQB: BTCY) (“the Company”), a modern medical technology company delivering disruptive solutions to the multi-billion-dollar cardiac monitoring and diagnostic market. Biotricity’s flagship Bioflux® product […]
Cloud-Based ECG Service Provides Continuous Monitoring and Full Disclosure Reports for Clinical Diagnostics SAN FRANCISCO, March 11, 2021 /PRNewswire/ — Qardio, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510k clearance for its QardioCore ambulatory ECG device. QardioCore will initially be marketed for holter monitoring applications, for use with […]
The latest ViSi Mobile software update integrates machine learning with increased speed to continue to provide world-class surveillance monitoring which wirelessly communicates critical data to clinicians and identifies physiological deterioration before it becomes a life-threatening event. San Diego, United States , March 09, 2021 (GLOBE NEWSWIRE) — Led by Dr. […]
Study Will Determine the Safety and Effectiveness of Pulsed Electrical Fields to Interrupt Irregular Heart Rhythms DUBLIN, March 4, 2021 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the first procedures in the investigational device exemption (IDE) pivotal trial to evaluate the PulseSelect™ Pulsed Field Ablation (PFA) System, a […]
Westport, CT, March 04, 2021 (GLOBE NEWSWIRE) — The patent is exclusively licensed from Mayo Foundation for Medical Education and Research Claims address methods and materials for improving the treatment of hypertension Fifteen additional licensed worldwide patent applications are pending, generally covering electroporation and stimulation BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or […]
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and simplify procedures for physicians MENLO PARK, Calif., March 3, 2021 /PRNewswire/ – FARAPULSE Inc. today announced the first patients were treated in the ADVENT Trial, a U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) pivotal trial to […]
